CA2753041A1 - Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents - Google Patents

Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents Download PDF

Info

Publication number
CA2753041A1
CA2753041A1 CA2753041A CA2753041A CA2753041A1 CA 2753041 A1 CA2753041 A1 CA 2753041A1 CA 2753041 A CA2753041 A CA 2753041A CA 2753041 A CA2753041 A CA 2753041A CA 2753041 A1 CA2753041 A1 CA 2753041A1
Authority
CA
Canada
Prior art keywords
hooi
compound
ammonium
pharmaceutical composition
lysine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2753041A
Other languages
English (en)
French (fr)
Inventor
Lee Roy Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dekk Tek Inc
Original Assignee
Dekk Tek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dekk Tek Inc filed Critical Dekk Tek Inc
Publication of CA2753041A1 publication Critical patent/CA2753041A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/40—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton with quaternised nitrogen atoms bound to carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA2753041A 2009-02-24 2010-02-24 Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents Abandoned CA2753041A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15507209P 2009-02-24 2009-02-24
US61/155,072 2009-02-24
PCT/US2010/025252 WO2010099213A1 (en) 2009-02-24 2010-02-24 Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents

Publications (1)

Publication Number Publication Date
CA2753041A1 true CA2753041A1 (en) 2010-09-02

Family

ID=42111918

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2753041A Abandoned CA2753041A1 (en) 2009-02-24 2010-02-24 Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents

Country Status (6)

Country Link
US (1) US8361992B2 (cg-RX-API-DMAC7.html)
EP (1) EP2401285B1 (cg-RX-API-DMAC7.html)
JP (1) JP5779106B2 (cg-RX-API-DMAC7.html)
AU (1) AU2010218109B2 (cg-RX-API-DMAC7.html)
CA (1) CA2753041A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010099213A1 (cg-RX-API-DMAC7.html)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5230519B2 (cg-RX-API-DMAC7.html) 1972-04-05 1977-08-09
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
ES2040394T3 (es) * 1988-03-19 1993-10-16 Asta Medica Aktiengesellschaft Procedimiento para preparar un material liofilizado de ifosfamida y mesna.
WO1993021173A1 (en) 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
WO2006000422A1 (de) * 2004-06-29 2006-01-05 Baxter International Inc. Verfahren zur herstellung von lagerstabiler mafosfamid-lysin-salz lyophilisat bulkware
CA2585125C (en) * 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) * 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체

Also Published As

Publication number Publication date
WO2010099213A1 (en) 2010-09-02
AU2010218109B2 (en) 2015-04-09
JP2012518659A (ja) 2012-08-16
EP2401285A1 (en) 2012-01-04
US20110319365A1 (en) 2011-12-29
JP5779106B2 (ja) 2015-09-16
EP2401285B1 (en) 2012-10-10
US8361992B2 (en) 2013-01-29
HK1165805A1 (en) 2012-10-12
AU2010218109A2 (en) 2011-09-22
AU2010218109A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
JP7675500B2 (ja) α線放出放射線核種の大環状錯体およびがんの標的放射線療法におけるそれらの使用
HK1209752A1 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US9340563B2 (en) Salts of isophosphoramide mustard and analogs thereof
JP2004510818A (ja) Ap/ampの改良プロドラッグ形態
AU2010218109B2 (en) Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
HK1165805B (en) Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
US20180117022A1 (en) Demethylpenclomedine analogs and their use as anti-cancer agents
HK1185884A (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150219

FZDE Discontinued

Effective date: 20180226